Last 12 months
Inside the activity.
1 purchase rows · 2632 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 142 |
| Dec 2025 | 0 | 143 |
| Jan 2026 | 0 | 78 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 364 |
| Apr 2026 | 0 | 346 |
| May 2026 | 1 | 340 |
| Jun 2026 | 0 | 298 |
| Jul 2026 | 0 | 240 |
| Aug 2026 | 0 | 251 |
| Sep 2026 | 0 | 260 |
| Oct 2026 | 0 | 144 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2025 Filed Aug 8, 2025 20:31 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 1,401 | $301.67 | $422,634.49 |
DisclosureSEC source: 0001562180-25-005691 · primarydocument.xml · nonDerivative · entry 6 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,881 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F6 · price: This transaction was executed in multiple trades at prices ranging from $301.18 to $302.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:31 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 2,837 | $300.47 | $852,424.03 |
DisclosureSEC source: 0001562180-25-005691 · primarydocument.xml · nonDerivative · entry 5 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,282 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F5 · price: This transaction was executed in multiple trades at prices ranging from $300.10 to $300.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:31 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 2,918 | $299.48 | $873,889.35 |
DisclosureSEC source: 0001562180-25-005691 · primarydocument.xml · nonDerivative · entry 4 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,119 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $299.06 to $300.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:31 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 1,353 | $298.73 | $404,179.39 |
DisclosureSEC source: 0001562180-25-005691 · primarydocument.xml · nonDerivative · entry 3 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,037 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $298.04 to $299.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:31 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 1,391 | $297.49 | $413,811.93 |
DisclosureSEC source: 0001562180-25-005691 · primarydocument.xml · nonDerivative · entry 2 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,390 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $297.04 to $298.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:31 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
Exercise / conversionCommon Stock | 11,000 | $135.42 | $1,489,620.00 |
DisclosureSEC source: 0001562180-25-005691 · primarydocument.xml · nonDerivative · entry 1 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:24 UTC |
KURZWEIL RAYDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 590 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005526 · primarydocument.xml · derivative · entry 2 KURZWEIL RAY · CIK 0001108501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 590 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:24 UTC |
KURZWEIL RAYDirector
|
Exercise / conversionCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005526 · primarydocument.xml · nonDerivative · entry 1 KURZWEIL RAY · CIK 0001108501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:27 UTC |
PATUSKY CHRISTOPHERDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 590 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005530 · primarydocument.xml · derivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 590 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:27 UTC |
PATUSKY CHRISTOPHERDirector
|
Exercise / conversionCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005530 · primarydocument.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:26 UTC |
Olian Judy D.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005529 · primarydocument.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:26 UTC |
Olian Judy D.Director
|
Exercise / conversionCommon Stock | 1,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005529 · primarydocument.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F1 · price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:26 UTC |
Mesa NildaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 590 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005528 · primarydocument.xml · derivative · entry 2 Mesa Nilda · CIK 0001756697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 590 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:26 UTC |
Mesa NildaDirector
|
Exercise / conversionCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005528 · primarydocument.xml · nonDerivative · entry 1 Mesa Nilda · CIK 0001756697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:24 UTC |
Giltner RichardDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005525 · primarydocument.xml · derivative · entry 2 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:24 UTC |
Giltner RichardDirector
|
Exercise / conversionCommon Stock | 1,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005525 · primarydocument.xml · nonDerivative · entry 1 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:21 UTC |
SULLIVAN LOUIS WDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 590 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005524 · primarydocument.xml · derivative · entry 3 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 0 Underlying: Common Stock · 590 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. F4 · ownership.nature: These restricted stock units were held indirectly by a trust over which the reporting person has sole investment power and sole voting power. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:21 UTC |
SULLIVAN LOUIS WDirector
|
Exercise / conversionCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005524 · primarydocument.xml · nonDerivative · entry 1 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · ownership.nature: These common stock shares are held indirectly by a trust over which the reporting person has sole investment power and sole voting power. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:13 UTC |
CAUSEY CHRISTOPHERDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005513 · primarydocument.xml · derivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:13 UTC |
CAUSEY CHRISTOPHERDirector
|
Exercise / conversionCommon Stock | 1,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005513 · primarydocument.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:10 UTC |
MALCOLM JANDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 590 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005511 · primarydocument.xml · derivative · entry 4 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 590 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:10 UTC |
MALCOLM JANDirector
|
Exercise / conversionCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005511 · primarydocument.xml · nonDerivative · entry 2 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 22:56 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
Exercise / conversionStock Option · Derivative | 11,000 | $0.00 Strike: $135.42 | $0.00 |
DisclosureSEC source: 0001562180-25-005508 · primarydocument.xml · derivative · entry 5 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,000 Underlying: Common Stock · 11,000 shares Expires 2027-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 22:56 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 2,254 | $305.14 | $687,795.48 |
DisclosureSEC source: 0001562180-25-005508 · primarydocument.xml · nonDerivative · entry 4 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,781 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $304.78 to $305.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 22:56 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 4,977 | $304.25 | $1,514,268.18 |
DisclosureSEC source: 0001562180-25-005508 · primarydocument.xml · nonDerivative · entry 3 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,035 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $303.78 to $304.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 22:56 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 3,769 | $303.31 | $1,143,161.44 |
DisclosureSEC source: 0001562180-25-005508 · primarydocument.xml · nonDerivative · entry 2 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,012 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $302.77 to $303.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 22:56 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
Exercise / conversionCommon Stock | 11,000 | $135.42 | $1,489,620.00 |
DisclosureSEC source: 0001562180-25-005508 · primarydocument.xml · nonDerivative · entry 1 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:24 UTC |
KURZWEIL RAYDirector
|
GrantStock Options · Derivative | 1,830 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005526 · primarydocument.xml · derivative · entry 4 KURZWEIL RAY · CIK 0001108501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,830 Underlying: Common Stock · 1,830 shares Expires 2035-07-24 F4 · shares: Annual non-employee director award. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:24 UTC |
KURZWEIL RAYDirector
|
GrantRestricted Stock Unit · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005526 · primarydocument.xml · derivative · entry 3 KURZWEIL RAY · CIK 0001108501 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650 Underlying: Common Stock · 650 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · shares: Annual non-employee director award. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:27 UTC |
Thompson Tommy GDirector
|
GrantStock Options · Derivative | 3,650 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005531 · primarydocument.xml · derivative · entry 1 Thompson Tommy G · CIK 0001324863 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2035-07-24 F1 · shares: Annual non-employee director award. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:27 UTC |
PATUSKY CHRISTOPHERDirector
|
GrantRestricted Stock Unit · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005530 · primarydocument.xml · derivative · entry 5 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650 Underlying: Common Stock · 650 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · shares: Annual non-employee director award. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:27 UTC |
PATUSKY CHRISTOPHERDirector
|
GrantStock Options · Derivative | 1,830 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005530 · primarydocument.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,830 Underlying: Common Stock · 1,830 shares Expires 2035-07-24 F4 · shares: Annual non-employee director award. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:26 UTC |
Olian Judy D.Director
|
GrantRestricted Stock Unit · Derivative | 1,310 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005529 · primarydocument.xml · derivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,310 Underlying: Common Stock · 1,310 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · shares: Annual non-employee director award. F1 · price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:26 UTC |
Mesa NildaDirector
|
GrantStock Options · Derivative | 1,830 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005528 · primarydocument.xml · derivative · entry 4 Mesa Nilda · CIK 0001756697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,830 Underlying: Common Stock · 1,830 shares Expires 2035-07-24 F4 · shares: Annual non-employee director award. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:26 UTC |
Mesa NildaDirector
|
GrantRestricted Stock Units · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005528 · primarydocument.xml · derivative · entry 3 Mesa Nilda · CIK 0001756697 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650 Underlying: Common Stock · 650 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · shares: Annual non-employee director award. F3 · price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:25 UTC |
MAXWELL LINDADirector
|
GrantStock Options · Derivative | 3,650 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005527 · primarydocument.xml · derivative · entry 1 MAXWELL LINDA · CIK 0001822674 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2035-07-24 F1 · shares: Annual non-employee director award. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:24 UTC |
Giltner RichardDirector
|
GrantRestricted Stock Unit · Derivative | 1,310 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005525 · primarydocument.xml · derivative · entry 3 Giltner Richard · CIK 0001460472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,310 Underlying: Common Stock · 1,310 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · shares: Annual non-employee director award. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:21 UTC |
SULLIVAN LOUIS WDirector
|
GrantStock Options · Derivative | 1,830 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005524 · primarydocument.xml · derivative · entry 5 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,830 Underlying: Common Stock · 1,830 shares Expires 2035-07-24 F6 · shares: Annual non-employee director award. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:21 UTC |
SULLIVAN LOUIS WDirector
|
GrantRestricted Stock Unit · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005524 · primarydocument.xml · derivative · entry 4 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650 Underlying: Common Stock · 650 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F6 · shares: Annual non-employee director award. F5 · price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:18 UTC |
DWEK RAYMONDDirector
|
GrantStock Options · Derivative | 3,650 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005523 · primarydocument.xml · derivative · entry 1 DWEK RAYMOND · CIK 0001231617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2035-07-24 F1 · shares: Annual non-employee director award. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:13 UTC |
CAUSEY CHRISTOPHERDirector
|
GrantStock Options · Derivative | 3,650 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005513 · primarydocument.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2035-07-24 F3 · shares: Annual non-employee director award. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:10 UTC |
MALCOLM JANDirector
|
GrantStock Options · Derivative | 1,830 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005511 · primarydocument.xml · derivative · entry 6 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,830 Underlying: Common Stock · 1,830 shares Expires 2035-07-24 F5 · shares: Annual non-employee director award. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:10 UTC |
MALCOLM JANDirector
|
GrantRestricted Stock Unit · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005511 · primarydocument.xml · derivative · entry 5 MALCOLM JAN · CIK 0002028640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650 Underlying: Common Stock · 650 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F5 · shares: Annual non-employee director award. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 10, 2025 Filed Jul 14, 2025 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
Exercise / conversionStock Option · Derivative | 11,000 | $0.00 Strike: $135.42 | $0.00 |
DisclosureSEC source: 0001562180-25-005409 · primarydocument.xml · derivative · entry 6 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 11,000 shares Expires 2027-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. Read SEC document |
| July 10, 2025 Filed Jul 14, 2025 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 1,358 | $301.20 | $409,023.22 |
DisclosureSEC source: 0001562180-25-005409 · primarydocument.xml · nonDerivative · entry 5 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,781 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F5 · price: This transaction was executed in multiple trades at prices ranging from $301.03 to $301.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 10, 2025 Filed Jul 14, 2025 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 7,738 | $300.48 | $2,325,108.05 |
DisclosureSEC source: 0001562180-25-005409 · primarydocument.xml · nonDerivative · entry 4 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,139 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $300.03 to $300.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 10, 2025 Filed Jul 14, 2025 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 1,304 | $299.49 | $390,530.00 |
DisclosureSEC source: 0001562180-25-005409 · primarydocument.xml · nonDerivative · entry 3 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,877 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $299.02 to $300.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 10, 2025 Filed Jul 14, 2025 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 600 | $297.89 | $178,732.44 |
DisclosureSEC source: 0001562180-25-005409 · primarydocument.xml · nonDerivative · entry 2 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,181 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $297.51 to $298.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 10, 2025 Filed Jul 14, 2025 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
Exercise / conversionCommon Stock | 11,000 | $135.42 | $1,489,620.00 |
DisclosureSEC source: 0001562180-25-005409 · primarydocument.xml · nonDerivative · entry 1 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. Read SEC document |
| June 26, 2025 Filed Jun 27, 2025 20:39 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
Exercise / conversionStock Option · Derivative | 11,000 | $0.00 Strike: $135.42 | $0.00 |
DisclosureSEC source: 0001562180-25-005102 · primarydocument.xml · derivative · entry 8 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,000 Underlying: Common Stock · 11,000 shares Expires 2027-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.